This report contains market size and forecasts of PD-1 Inhibitor in Global, including the following market information:
Global PD-1 Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PD-1 Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pembrolizumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-1 Inhibitor include Merck, Novartis, Onxeo, Sumitomo Dainippon Pharma, Taiwan Liposome Company, Tiziana Life Sciences, Genentech (Roche), AstraZeneca and Pfizer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-1 Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-1 Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PD-1 Inhibitor Market Segment Percentages, by Type, 2021 (%)
Pembrolizumab
Nivolumab
Atezolizumab
Durvalumab
Avelumab
Other
Global PD-1 Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PD-1 Inhibitor Market Segment Percentages, by Application, 2021 (%)
Melanoma
Non-small Cell Lung Cancer (NSCLC)
Urothelial Carcinoma
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Global PD-1 Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PD-1 Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PD-1 Inhibitor revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PD-1 Inhibitor revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Onxeo
Sumitomo Dainippon Pharma
Taiwan Liposome Company
Tiziana Life Sciences
Genentech (Roche)
AstraZeneca
Pfizer